跳至主要内容
临床试验/JPRN-UMIN000039155
JPRN-UMIN000039155已完成未知

Fpllow-up study of multicenter, prospective, randomised and comparative study of alternative anti-androgen (AA) therapy and early initiating enzalutamide for castration-resistant prostate cancer (CRPC) after combined androgen blockade (CAB) therapy with bicalutamide (OCUU-CRPC follow-up study). - Fpllow-up study of multicenter, prospective, randomised and comparative study of alternative anti-androgen (AA) therapy and early initiating enzalutamide for castration-resistant prostate cancer (CRPC) after combined androgen blockade (CAB) therapy with bicalutamide (OCUU-CRPC follow-up study).

Department of Urology, Osaka City University Graduate School of Medicine0 个研究点目标入组 103 人开始时间: 2020年1月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
103